ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (ADCT)

Q: What does CUSIP H0036K147 represent in this 13F holders report?

CUSIP H0036K147 is the security identifier for ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share used to aggregate holder disclosures.

Q: How many institutions held ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share in Q4 2024?

82 institutional investors reported ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share for Q4 2024. Use the holders table for investor-level position and value details.

CUSIP: H0036K147

Q4 2024 13F Holders as of 31 Dec 2024

Security type / class: Equity / Common Shares, par value CHF 0.08 per share
Total 13F shares: 56,494,277
Total 13F value: $112,422,732
Share change: +847,366
Put/Call ratio: 185%
SEC-reported price per share: $1.99
Number of holders: 82
Value change: -$3,041,138
Number of buys: 45
Number of sells: 26
Shares outstanding: 148,404,655

Security key

H0036K147

Report period

Q4 2024

Institutions

Top holders

ADCT full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 ADC Therapeutics SA SEC filings ADC Therapeutics SA company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP H0036K147

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026

Ownership snapshot

Top reported holders of ADCT - ADC Therapeutics SA - Common Shares, par value CHF 0.08 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Redmile Group, LLC

Disclosed value leader

Redmile Group, LLC

Comparable rows

0/15

Latest evidence

30 Sep 2024

13F Highest disclosed value: $49,358,034 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Redmile Group, LLC has the largest disclosed position value at $49.36M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Redmile Group, LLC's linked filing trail.

Disclosed position value Top 5

Redmile Group, LLC $49.36M

Prosight Management, LP $30.35M

ORBIMED ADVISORS LLC $14.28M

BlackRock, Inc. $13.86M

MORGAN STANLEY $9.58M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Redmile Group, LLC	13F Company 13F	— denominator unverified	$49,358,034 15,669,217 shares	—	30 Sep 2024
Prosight Management, LP	13F Company 13F	— denominator unverified	$30,354,147 9,636,237 shares	—	30 Sep 2024
ORBIMED ADVISORS LLC	13F Company 13F	— denominator unverified	$14,281,473 4,533,801 shares	—	30 Sep 2024
BlackRock, Inc.	13F Company 13F	— denominator unverified	$13,857,274 4,399,134 shares	—	30 Sep 2024
MORGAN STANLEY	13F Company 13F	— denominator unverified	$9,578,500 3,040,794 shares	—	30 Sep 2024
BANK OF AMERICA CORP /DE/	13F Company 13F	— denominator unverified	$7,868,511 2,497,940 shares	—	30 Sep 2024

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q4 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

56,494,277

Rows available

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q4 2024 vs Q3 2024 Across Filers

Q3 2024 holders

Q4 2024 holders

Holder diff

Investor	Q3 2024 Shares	Q4 2024 Shares	Share Diff	Share Chg %	Q3 2024 value	Q4 2024 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend